Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Product Detail
They are not intended for human or veterinary use and must be handled only by qualified researchers within appropriate laboratory environments
Clinical research has indicated that FOXO4-DRI has shown promise in the following areas: Targets senescent cells FOXO4-DRI is a synthetic peptide designed to target senescent cells, which are damaged cells that stop dividing but resist apoptosis (programmed cell death)
Measurement of Isoprostanes as Markers of Oxidative Stress in Neuronal Tissue
TB-500 (Thymosin Beta-4) Phase I and Phase II safety trials of intravenous thymosin beta-4 published in human cohorts (Ruff et al., 2010)
US$ 20.43
US$ 27.73
US$ 24.59
US$ 29.35
